Back to Journals » OncoTargets and Therapy » Volume 18

Crosstalk Between EGFR and Integrin Affects Invasion and Proliferation of Gastric Cancer Cell Line, SGC7901 [Retraction]

Authors Dan L, Jian D, Na L, Xiaozhong W

Received 5 June 2025

Accepted for publication 5 June 2025

Published 10 June 2025 Volume 2025:18 Pages 733—734

DOI https://doi.org/10.2147/OTT.S544936



Dan L, Jian D, Na L, Xiaozhong W. Onco Targets Ther. 2012;5:271—277.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the published article.

Following publication, a third party raised concerns regarding repeated sections of images in figure 5a that should represent different experimental conditions. Following these concerns being raised, the authors then contacted the journal to request a correction to the figure.

When asked for an explanation regarding the concerns, the authors explained that Figure 5 had been misused. Following an investigation, as verifying the validity of the published work is core to the integrity of the scholarly record, the Editor and Publisher do not believe the concerns can be addressed with a correction, and we are therefore retracting the article. All authors listed in this publication have been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.


This retraction relates to this paper


Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.